Read More

Kodiak Sciences Data At ARVO 2024 Highlight Depth Of Early And Late-Phase Retina Pipeline Including Advancements With High Drug-Antibody-Ratio Therapeutics Built On Kodiak’s Antibody Biopolymer Conjugate Platform

Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data highlight multiple

KOD

Read More

enGene To Present Details Of Its Pivotal Phase 1/2 LEGEND Study Of EG-70 In BCG-Unresponsive Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ At The American Urology Association 2024 Annual Meeting

Oral presentation highlights rational design of EG-70 to address challenges faced by other intravesical treatment options, including preparation, handling, and safety considerationsBOSTON and MONTREAL, May 2, 2024 /CNW/

ENGN

Read More

Starbucks CEO’s Dilemma Unfolds With Stock Performance, Falling Sales

Starbucks' honeymoon with new CEO Laxman Narasimhan ends abruptly as shares plummet 18% post-disappointing quarterly results. Global comparable store sales sink by 4%, with transactions down by 6%. Bloomberg reports efforts to revive fortunes include efficiency boosts, discounts, and new offerings like a boba-inspired drink. But with user frustration over app service and supply chain woes, Starbucks braces for a prolonged recovery, dampening full-year forecasts and investor confidence.

SBUX